Skip to content
Menu

Update: Spero Therapeutics Q3 Adj. EPS $(0.16) Beats $(0.47) Estimate

Benzinga Newsdesk 6 days ago

NewsEarningsEarnings Beats

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.47) by 65.96 percent. This is a 23.08 percent decrease over losses of $(0.13) per share

Spero Therapeutics (NASDAQ:SPRO) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.47) by 65.96 percent. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last year.

Read at benzinga.com